Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests

结直肠肿瘤血液筛查试验的评估；

• 批准号: nhmrc : 1006242
• 负责人: A/Pr Michael Michael
• 金额: $ 51.17万
• 依托单位: Flinders University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/evaluation-blood-based-acceptable-tests/109158
• 关键词: Evaluation; blood; based; screening; tests

Current bowel cancer screening tests require people to collect a stool sample. While able to be done at home, this creates certain inconveniences and has other barriers to its use including being distasteful to some. Also, even though stool tests are useful they are not as accurate as we would like. We have discovered a molecule in the blood of patients with bowel cancer that could, if configured as a screening test, serve to be of even greater accuracy and also be more acceptable to people.

目前的肠癌筛查测试需要人们收集粪便样本。虽然可以在家里完成，但这会造成某些不便，并对其使用有其他障碍，包括对某些人来说令人反感。此外，即使粪便测试是有用的，它们也不像我们希望的那样准确。我们已经在肠癌患者的血液中发现了一种分子，如果将其配置为筛查测试，可以提供更高的准确性，也更容易被人们接受。